A study assessing safety and efficacy of MD-16 intraocular lens in patients with aphakic eye after cataract surgery
Phase 3
Completed
- Conditions
- Cataract
- Registration Number
- JPRN-jRCT1080223821
- Lead Sponsor
- SANTEN PHARMACEUTICAL Co., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 59
Inclusion Criteria
Subjects scheduled to remove the lens by phacoemulsification and aspiration
Exclusion Criteria
Subjects with indication for secondary lens implantation
Subjects with visual loss induced by causes other than cataract
Subjects who judged inappropriate of this study by principal investigator / subinvestigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy<br>Visual acuity after surgery
- Secondary Outcome Measures
Name Time Method safety<br>efficacy<br>Visual acuity, adverse events, etc.